NYSEAMERICAN:CPHI - China Pharma Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.28 -0.01 (-3.45 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$0.28
Today's Range$0.26 - $0.28
52-Week Range$0.15 - $1.45
Volume309,200 shs
Average Volume1.14 million shs
Market Capitalization$14.73 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

About China Pharma (NYSEAMERICAN:CPHI)

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CPHI
CUSIPN/A
Phone+86-898-66811730

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-69.43%
Return on Equity-15.43%
Return on Assets-11.58%

Miscellaneous

EmployeesN/A
Outstanding Shares43,580,000

China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) released its earnings results on Tuesday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $3.62 million during the quarter. China Pharma had a negative net margin of 69.43% and a negative return on equity of 15.43%. View China Pharma's Earnings History.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest in April. As of April 30th, there was short interest totalling 183,799 shares, an increase of 62.2% from the April 13th total of 113,291 shares. Based on an average trading volume of 363,252 shares, the short-interest ratio is presently 0.5 days. Currently, 0.8% of the company's stock are sold short.

Who are some of China Pharma's key competitors?

Who are China Pharma's key executives?

China Pharma's management team includes the folowing people:
  • Ms. Zhilin Li, Chairman, Pres, CEO & Interim CFO (Age 65)
  • Ms. Yao Huang, Chief Technical Officer
  • Ms. Jian Yang, Sec. (Age 58)

Has China Pharma been receiving favorable news coverage?

News articles about CPHI stock have trended somewhat negative this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Pharma earned a daily sentiment score of -0.01 on Accern's scale. They also gave press coverage about the company an impact score of 46.32 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.28.

How big of a company is China Pharma?

China Pharma has a market capitalization of $14.73 million.

How can I contact China Pharma?

China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at +86-898-66811730.


MarketBeat Community Rating for China Pharma (CPHI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  82
MarketBeat's community ratings are surveys of what our community members think about China Pharma and other stocks. Vote "Outperform" if you believe CPHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

China Pharma (NYSEAMERICAN:CPHI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/22/2016 forward)

Earnings

China Pharma (NYSEAMERICAN:CPHI) Earnings History and Estimates Chart

Earnings by Quarter for China Pharma (NYSEAMERICAN:CPHI)

China Pharma (NYSEAMERICAN CPHI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/20183/31/2018($0.01)$3.62 millionViewListenView Earnings Details
4/3/2018Q4 2017($0.32)$3.85 millionViewN/AView Earnings Details
11/15/2017Q3 17($0.05)$3.16 millionViewN/AView Earnings Details
8/15/2017Q2 2017($0.05)$2.92 millionViewN/AView Earnings Details
5/12/2017Q1 17($0.02)$3.29 millionViewN/AView Earnings Details
3/31/2017Q4 2016($0.08)$5.26 millionViewN/AView Earnings Details
11/15/2016Q316($0.04)$26.78 million$3.10 millionViewN/AView Earnings Details
8/11/2016Q216($0.06)$26.78 million$3.50 millionViewN/AView Earnings Details
5/17/2016Q116($0.04)$26.78 million$3.60 millionViewN/AView Earnings Details
3/31/2016Q4 2015$0.02$4.50 millionViewN/AView Earnings Details
11/17/2015Q315($0.10)$26.78 million$4.80 millionViewN/AView Earnings Details
8/14/2015Q215($0.09)$26.78 million$5.70 millionViewN/AView Earnings Details
5/12/2015Q115($0.18)$26.78 million$5.70 millionViewN/AView Earnings Details
3/31/2015Q4 2014($0.20)$6.13 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.15)$5.57 millionViewN/AView Earnings Details
8/15/2014Q2 14($0.20)$8.00 million$6.10 millionViewN/AView Earnings Details
5/15/2014Q114($0.05)$8.20 million$7.10 millionViewN/AView Earnings Details
3/21/2014Q4 2013($0.24)$8.41 millionViewN/AView Earnings Details
11/15/2013Q313($0.05)$12.20 million$8.10 millionViewN/AView Earnings Details
8/14/2013Q2 2013($0.10)$8.03 millionViewN/AView Earnings Details
5/15/2013Q1 2013($0.06)$8.25 millionViewListenView Earnings Details
3/15/2013Q4 2012($0.01)ViewN/AView Earnings Details
11/15/2012Q3 2012$0.03ViewN/AView Earnings Details
8/15/2012Q2 2012$0.04ViewN/AView Earnings Details
5/15/2012Q1 2012$0.06ViewN/AView Earnings Details
3/15/2012Q4 2011$0.13ViewN/AView Earnings Details
11/11/2011Q3 2011$0.12$0.08ViewN/AView Earnings Details
8/11/2011Q2 2011$0.12$0.11ViewN/AView Earnings Details
5/11/2011Q1 2011$0.12$0.10ViewN/AView Earnings Details
3/3/2011Q4 2010$0.16$0.15ViewN/AView Earnings Details
11/11/2010Q3 2010$0.13$0.13ViewN/AView Earnings Details
8/10/2010Q2 2010$0.11$0.12ViewN/AView Earnings Details
5/11/2010Q1 2010$0.11$0.10ViewN/AView Earnings Details
3/5/2010Q4 2009$0.13$0.12ViewN/AView Earnings Details
11/11/2009Q3 2009$0.12$0.17ViewN/AView Earnings Details
8/11/2009Q2 2009$0.10$0.10ViewN/AView Earnings Details
5/15/2009Q1 2009$0.13$0.09ViewN/AView Earnings Details
3/17/2009Q4 2008$0.11$0.12ViewN/AView Earnings Details
11/7/2008Q3 2008$0.10ViewN/AView Earnings Details
8/6/2008Q2 2008$0.10ViewN/AView Earnings Details
5/2/2008Q1 2008$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

China Pharma (NYSEAMERICAN:CPHI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

China Pharma (NYSEAMERICAN CPHI) Insider Trading and Institutional Ownership History

Insider Trading History for China Pharma (NYSEAMERICAN:CPHI)

China Pharma (NYSEAMERICAN CPHI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

China Pharma (NYSEAMERICAN CPHI) News Headlines

Source:
DateHeadline
China Pharma (CPHI) Posts Quarterly  Earnings ResultsChina Pharma (CPHI) Posts Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 2:21 PM
China Pharma revenues up 9%; net loss improves in Q1China Pharma revenues up 9%; net loss improves in Q1
seekingalpha.com - May 15 at 10:37 AM
China Pharma Holdings (CPHI) CEO Zhilin Li on Q1 2018 Results - Earnings Call TranscriptChina Pharma Holdings' (CPHI) CEO Zhilin Li on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 10:37 AM
China Pharma Holdings, Inc. (CPHI) Sees Significant Growth in Short InterestChina Pharma Holdings, Inc. (CPHI) Sees Significant Growth in Short Interest
www.americanbankingnews.com - May 9 at 5:49 PM
CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ETCPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET
finance.yahoo.com - May 8 at 9:49 AM
Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSDBlog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD
finance.yahoo.com - April 5 at 8:27 AM
China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial ResultsChina Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results
finance.yahoo.com - April 3 at 10:20 AM
China Pharma Holdings, Inc. (CPHI) Sees Large Decline in Short InterestChina Pharma Holdings, Inc. (CPHI) Sees Large Decline in Short Interest
www.americanbankingnews.com - March 27 at 1:02 AM
CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ETCPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET
finance.yahoo.com - March 22 at 10:12 AM
China Pharma (CPHI) Scheduled to Post Quarterly Earnings on ThursdayChina Pharma (CPHI) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - March 22 at 1:14 AM
GNC Holdings Expands in India, Boosts International BusinessGNC Holdings Expands in India, Boosts International Business
www.msn.com - March 12 at 4:59 PM
China Pharma Holdings, Inc. (CPHI) Sees Large Increase in Short InterestChina Pharma Holdings, Inc. (CPHI) Sees Large Increase in Short Interest
www.americanbankingnews.com - March 9 at 6:23 PM
Short Interest in China Pharma Holdings, Inc. (CPHI) Drops By 95.0%Short Interest in China Pharma Holdings, Inc. (CPHI) Drops By 95.0%
www.americanbankingnews.com - February 28 at 1:08 AM
GNCs stock rockets after big investment from Chinas Harbin PharmaceuticalGNC's stock rockets after big investment from China's Harbin Pharmaceutical
www.marketwatch.com - February 13 at 8:47 AM
China Pharma Holdings, Inc. (CPHI) Short Interest Up 71.6% in DecemberChina Pharma Holdings, Inc. (CPHI) Short Interest Up 71.6% in December
www.americanbankingnews.com - December 27 at 7:24 PM
Walgreens Boots Alliance (WBA) Enters Pact to Reduce Stake in Guangzhou Pharmaceuticals CorporationWalgreens Boots Alliance (WBA) Enters Pact to Reduce Stake in Guangzhou Pharmaceuticals Corporation
www.streetinsider.com - December 22 at 9:19 AM
China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017
finance.yahoo.com - December 1 at 4:32 PM
China, Hong Kong stocks fall on caution after N.Korea missile testChina, Hong Kong stocks fall on caution after N.Korea missile test
www.reuters.com - November 29 at 9:10 AM
China Pharma Holdings, Inc. (CPHI) Short Interest UpdateChina Pharma Holdings, Inc. (CPHI) Short Interest Update
www.americanbankingnews.com - November 27 at 9:56 PM
Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in ChinaConavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in China
www.businesswire.com - November 16 at 6:07 PM
EARNINGS SUMMARY: Details of China Pharma Holdings Inc. Q3 Earnings ReportEARNINGS SUMMARY: Details of China Pharma Holdings Inc. Q3 Earnings Report
www.rttnews.com - November 16 at 6:07 PM
China Pharma Holdings (CPHI) CEO Zhilin Li on Q3 2017 Results - Earnings Call TranscriptChina Pharma Holdings' (CPHI) CEO Zhilin Li on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 16 at 6:07 PM
China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial ResultsChina Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 16 at 1:03 PM
China Pharma Holdings, Inc. (CPHI) Announces Quarterly  Earnings ResultsChina Pharma Holdings, Inc. (CPHI) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 16 at 9:44 AM
Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ...Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ...
www.nasdaq.com - November 15 at 4:51 AM

SEC Filings

China Pharma (NYSEAMERICAN:CPHI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

China Pharma (NYSEAMERICAN CPHI) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.